Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Neurobiology of Disease · 2023-05 · 180 · 106090
DOI: 10.1016/j.nbd.2023.106090 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurobiology of Disease, 2023-05. Verfasst von Yujiao Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States of America. Electronic address: yulu@aug…. Hauptthemen laut MEDLINE: Cognitive Aging, Brain Injuries, Traumatic. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Traumatic brain injury (TBI) is associated with mortality and morbidity worldwide. Accumulating pre-clinical and clinical data suggests TBI is the leading extrinsic cause of progressive neurodegeneration. Neurological deterioration after either a single moderate-severe TBI or repetitive mild TBI often resembles dementia in aged populations; however, no currently approved therapies adequately mitigate neurodegeneration. Inflammation correlates with neurodegenerative changes and cognitive dysfunction for years post-TBI, suggesting a potential association between immune activation and both age- and TBI-induced cognitive decline. Inflammaging, a chronic, low-grade sterile inflammation associated with natural aging, promotes cognitive decline. Cellular senescence and the subsequent development of a senescence associated secretory phenotype (SASP) promotes inflammaging and cognitive aging, although the functional association between senescent cells and neurodegeneration is poorly defined after TBI. In this mini-review, we provide an overview of the pre-clinical and clinical evidence linking cellular senescence with poor TBI outcomes. We also discuss the current knowledge and future potential for senotherapeutics, including senolytics and senomorphics, which kill and/or modulate senescent cells, as potential therapeutics after TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States of America. Electronic address: yulu@augusta.edu.
- Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States of America.
- Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States of America.
- Department of Oral Biology and Diagnostic Services, Dental College of Georgia, Augusta University, Augusta, GA 30912, United States of America.
- Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States of America. Electronic address: kdhandapani@augusta.edu.
Förderung
- NINDS NIH HHS
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Lu, Y., Jarrahi, A., Moore, N., Bartoli, M., Brann, D. W., Baban, B., & Dhandapani, K. M. (2023). Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury. Neurobiology of Disease, 180, 106090. https://doi.org/10.1016/j.nbd.2023.106090
Vancouver
Lu Y, Jarrahi A, Moore N, Bartoli M, Brann DW, Baban B, et al. Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury. Neurobiology of Disease. 2023;180:106090. doi:10.1016/j.nbd.2023.106090
BibTeX
@article{Lu2023,
author = {Lu, Yujiao and Jarrahi, Abbas and Moore, Nicholas and Bartoli, Manuela and Brann, Darrell W and Baban, Babak and Dhandapani, Krishnan M},
title = {Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury},
journal = {Neurobiology of Disease},
year = {2023},
volume = {180},
pages = {106090},
doi = {10.1016/j.nbd.2023.106090}
}
EUVIMED